Prospective, Multicenter, Epidemiological Study To Determine The Clinical, Molecular And Genetic Factors Associated To The Prognosis Of Patients With Advanced Renal Cell Carcinoma
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Carcinoma, Renal Cell
Both
Carcinoma, Renal Cell
Trial Information
Prospective, Multicenter, Epidemiological Study To Determine The Clinical, Molecular And Genetic Factors Associated To The Prognosis Of Patients With Advanced Renal Cell Carcinoma
invitation to volunteer
Inclusion Criteria:
- Treatment naïve patients with proven advanced RCC will be evaluated. (Except surgery
or radiotherapy)
- =18 years, any gender.
- Patients with advanced Renal Cell Carcinoma and treatment naïve.
Exclusion Criteria:
- Patients who have already initiated any kind of specific therapy for the treatment of
RCC.2.
- Patients with other neoplasias different from RCC (current or past).
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Progression-free survival
Outcome Time Frame:
12 months
Safety Issue:
No
Principal Investigator
Pfizer CT.gov Call Center
Investigator Role:
Study Director
Investigator Affiliation:
Pfizer
Authority:
Spain: Comite de Investigacion Clinica
Study ID:
3066K1-4433
NCT ID:
NCT00927043
Start Date:
May 2009
Completion Date:
September 2011
Related Keywords:
- Carcinoma, Renal Cell
- Carcinoma
- Carcinoma, Renal Cell
Name | Location |
|---|
